Abstract
In this chapter, we discuss the use of anti-biofilm agents as critical players for achieving healing of chronic wounds. These types of wounds are typically persistent due to the presence of biofilms that become a major barrier toward healing.
RNAIII inhibiting peptide (RIP) is the main anti-biofilm agent described in this chapter. By functional genomics (microarray analysis), RIP was shown in Staphylococcus aureus to downregulate the expression of genes involved in biofilm formation. Such genes participate both in neutralizing acidic pH and enabling survival in an anaerobic environment. RIP was also shown to downregulate the production of multiple toxins, yielding nonpathogenic bacteria.
The implementation of the general use of RIP in managing complex wounds, along with other anti-biofilm strategies, dramatically changed the outcomes for many of the most desperate wounds. The amazing improvement in wound healing trajectory is best explained by the suppression of staphylococcal biofilms.
Hopefully, the evidence gathered will help establish changes in the way clinicians tackle chronic persistent wounds. Instead of amputation, the concept of healing might become a better alternative with the addition of anti-biofilm agents to the existing protocols.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Almiron M, Link AJ, Furlong D, Kolter R (1992) A novel DNA-binding protein with regulatory and protective roles in starved Escherichia coli. Genes Dev 6:2646–54
Amy P (2008) Interview with Dr. Randall Wolcott, bacterial biofilm wound specialist. Bacteriality 2008, April 13
An APIC Guide, 2010, Guide to the Elimination of Methicillin-Resistant Staphylococcus aureus (MRSA) Transmission in Hospital Settings (http://www.apic.org/downloads/MRSA_elimination_guide_27030.pdf
Anguita-Alonso P, Giacometti A, Cirioni O et al (2007) RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob Agents Chemother 51:2594–6
Baker J, Sitthisak S, Sengupta M, Johnson M, Jayaswal RK, Morrissey JA (2010) Copper stress induces a global stress response in Staphylococcus aureus and represses sae and agr expression and biofilm formation. Appl Environ Microbiol 76:150–160
Balaban N, Novick RP (1995) Autocrine regulation of toxin synthesis by Staphylococcus aureus. Proc Natl Acad Sci U S A 92:1619–23
Balaban N, Goldkorn T, Nhan RT et al (1998) Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280:438–40
Balaban N, Collins LV, Cullor JS et al (2000) Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 21:1301–11
Balaban N, Goldkorn T, Gov Y et al (2001) Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP). J Biol Chem 276:2658–67
Balaban N, Giacometti A, Cirioni O et al (2003a) Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 187:625–30
Balaban N, Gov Y, Bitler A, Boelaert JR (2003b) Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int 63:340–5
Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell’Acqua G (2005) Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 437:48–54
Balaban N, Cirioni O, Giacometti A et al (2007) Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 51:2226–9
Beenken KE, Dunman PM, McAleese F et al (2004) Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186:4665–84
Bjarnsholt T, Kirketerp-Moller K, Kristiansen S et al (2007) Silver against Pseudomonas aeruginosa biofilms. APMIS 115:921–8
Boor KJ (2006) Bacterial stress responses: what doesn’t kill them can make then stronger. PLoS Biol 4:e23
Chang W, Toghrol F, Bentley WE (2006) Toxicogenomic response of Staphylococcus aureus to peracetic acid. Environ Sci Technol 40:5124–31
Chastanet A, Fert J, Msadek T (2003) Comparative genomics reveal novel heat shock regulatory mechanisms in Staphylococcus aureus and other gram-positive bacteria. Mol Microbiol 47:1061–73
Chatterjee I, Schmitt S, Batzilla CF et al (2009) Staphylococcus aureus ClpC ATPase is a late growth phase effector of metabolism and persistence. Proteomics 9:1152–76
Chatterjee I, Neumayer D, Herrmann M (2010) Senescence of staphylococci: using functional genomics to unravel the roles of ClpC ATPase during late stationary phase. Int J Med Microbiol 300:130–136
Cirioni O, Giacometti A, Ghiselli R et al (2003) Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation 108:767–71
Cirioni O, Giacometti A, Ghiselli R et al (2006) RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis 193:180–6
Clements MO, Foster SJ (1999) Stress resistance in Staphylococcus aureus. Trends Microbiol 7:458–62
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–22
Dell’Acqua G, Giacometti A, Cirioni O et al (2004) Suppression of drug-resistant Staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis 190:318–20
DeRisi JL, Iyer VR, Brown PO (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278:680–6
Derre I, Rapoport G, Msadek T (1999) CtsR, a novel regulator of stress and heat shock response, controls clp and molecular chaperone gene expression in gram-positive bacteria. Mol Microbiol 31:117–31
Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D (2008) Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS ONE 3:e3326
Dunman PM, Murphy E, Haney S et al (2001) Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 183:7341–53
Ehrlich GD, Hu FZ, Shen K, Stoodley P, Post JC (2005) Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin Orthop Relat Res 20–24
Fang FC (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2:820–32
Fleury B, Kelley WL, Lew D, Gotz F, Proctor RA, Vaudaux P (2009) Transcriptomic and metabolic responses of Staphylococcus aureus exposed to supra-physiological temperatures. BMC Microbiol 9:76
Frees D, Chastanet A, Qazi S et al (2004) Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus. Mol Microbiol 54:1445–62
Frees D, Sorensen K, Ingmer H (2005) Global virulence regulation in Staphylococcus aureus: pinpointing the roles of ClpP and ClpX in the sar/agr regulatory network. Infect Immun 73:8100–8
Frenkiel-Krispin D, Ben-Avraham I, Englander J, Shimoni E, Wolf SG, Minsky A (2004) Nucleoid restructuring in stationary-state bacteria. Mol Microbiol 51:395–405
Gasch AP, Spellman PT, Kao CM et al (2000) Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 11:4241–57
Gerth U, Kruger E, Derre I, Msadek T, Hecker M (1998) Stress induction of the Bacillus subtilis clpP gene encoding a homologue of the proteolytic component of the Clp protease and the involvement of ClpP and ClpX in stress tolerance. Mol Microbiol 28:787–802
Ghiselli R, Giacometti A, Cirioni O et al (2006) RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis. Shock 26:296–301
Giacometti A, Cirioni O, Gov Y et al (2003) RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:1979–83
Giacometti A, Cirioni O, Ghiselli R et al (2005) RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. Peptides 26:169–75
Gov Y, Borovok I, Korem M et al (2004) Quorum sensing in Staphylococci is regulated via phosphorylation of three conserved histidine residues. J Biol Chem 279:14665–72
Gupta S, Chatterji D (2003) Bimodal protection of DNA by Mycobacterium smegmatis DNA-binding protein from stationary phase cells. J Biol Chem 278:5235–41
Harrison JJ, Turner RJ, Joo DA et al (2008) Copper and quaternary ammonium cations exert synergistic bactericidal and antibiofilm activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 52:2870–81
Hetrick EM, Shin JH, Paul HS, Schoenfisch MH (2009) Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 30:2782–9
Imlay JA (2003) Pathways of oxidative damage. Annu Rev Microbiol 57:395–418
James GA, Swogger E, Wolcott R et al (2008) Biofilms in chronic wounds. Wound Repair Regen 16:37–44
Kiran MD, Bala S, Hirshberg M, Balaban N (2010) YhgC protects Bacillus anthracis from oxidative stress. Int J Artif Organs. 33:590–607
Kiran MD, Balaban N (2009) TRAP plays a role in stress response in Staphylococcus aureus. Int J Artif Organs 32:592–9
Kiran MD, Giacometti A, Cirioni O, Balaban N (2008a) Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. Int J Artif Organs 31:761–70
Kiran MD, Adikesavan NV, Cirioni O et al (2008b) Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol Pharmacol 73:1578–86
Kirdis E, Jonsson IM, Kubica M et al (2007) Ribonucleotide reductase class III, an essential enzyme for the anaerobic growth of Staphylococcus aureus, is a virulence determinant in septic arthritis. Microb Pathog 43:179–88
Korem M, Sheoran AS, Gov Y, Tzipori S, Borovok I, Balaban N (2003) Characterization of RAP, a quorum sensing activator of Staphylococcus aureus. FEMS Microbiol Lett 223:167–75
Kruger E, Volker U, Hecker M (1994) Stress induction of clpC in Bacillus subtilis and its involvement in stress tolerance. J Bacteriol 176:3360–7
Levin-Zaidman S, Frenkiel-Krispin D, Shimoni E, Sabanay I, Wolf SG, Minsky A (2000) Ordered intracellular RecA-DNA assemblies: a potential site of in vivo RecA-mediated activities. Proc Natl Acad Sci U S A 97:6791–6
Lopez-Leban F, Kiran MD, Wolcott R, Balaban N (2010) Molecular mechanisms of RIP, an effective inhibitor of chronic infections. Int J Artif Organs 33:582–9
Liu X, Hintze K, Lonnerdal B, Theil EC (2006a) Iron at the center of ferritin, metal/oxygen homeostasis and novel dietary strategies. Biol Res 39:167–71
Liu X, Kim K, Leighton T, Theil EC (2006b) Paired Bacillus anthracis Dps (mini-ferritin) have different reactivities with peroxide. J Biol Chem 281:27827–35
Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520–32
Makhlin J, Kofman T, Borovok I et al (2007) Staphylococcus aureus ArcR controls expression of the arginine deiminase operon. J Bacteriol 189:5976–86
Morikawa K, Ohniwa RL, Kim J, Maruyama A, Ohta T, Takeyasu K (2006) Bacterial nucleoid dynamics: oxidative stress response in Staphylococcus aureus. Genes Cells 11:409–23
Msadek T, Kunst F, Rapoport G (1994) MecB of Bacillus subtilis, a member of the ClpC ATPase family, is a pleiotropic regulator controlling competence gene expression and growth at high temperature. Proc Natl Acad Sci U S A 91:5788–92
Msadek T, Dartois V, Kunst F, Herbaud ML, Denizot F, Rapoport G (1998) ClpP of Bacillus subtilis is required for competence development, motility, degradative enzyme synthesis, growth at high temperature and sporulation. Mol Microbiol 27:899–914
Nair S, Finkel SE (2004) Dps protects cells against multiple stresses during stationary phase. J Bacteriol 186:4192–8
Narisawa N, Haruta S, Arai H, Ishii M, Igarashi Y (2008) Coexistence of antibiotic-producing and antibiotic-sensitive bacteria in biofilms is mediated by resistant bacteria. Appl Environ Microbiol 74:3887–94
Novick RP, Geisinger E (2008) Quorum sensing in staphylococci. Annu Rev Genet 42:541–64
O’Connell HA, Kottkamp GS, Eppelbaum JL, Stubblefield BA, Gilbert SE, Gilbert ES (2006) Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm. Appl Environ Microbiol 72:5013–9
Schlag S, Fuchs S, Nerz C et al (2008) Characterization of the oxygen-responsive NreABC regulon of Staphylococcus aureus. J Bacteriol 190:7847–58
Schierle CF, De la Garza M, Mustoe TA, Galiano RD (2009) Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Rep Reg 17:354–59
Schumann W (2003) The Bacillus subtilis heat shock stimulon. Cell Stress Chaperones 8:207–17
Vieira-da-Motta O, Ribeiro PD, Dias da Silva W, Medina-Acosta E (2001) RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production. Peptides 22:1621–7
Wolcott RD, Ehrlich GD (2008) Biofilms and chronic infections. JAMA 299:2682–4
Wolcott RD, Rhoads DD (2008) A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 17:145–8, 150–152, 154–155
Wolcott RD, Gontcharova V, Sun Y, Zischakau A, Dowd SE (2009) Bacterial diversity in surgical site infections: not just aerobic cocci any more. J Wound Care 18:317–23
Wolf SG, Frenkiel D, Arad T, Finkel SE, Kolter R, Minsky A (1999) DNA protection by stress-induced biocrystallization. Nature 400:83–5
Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R (2008) Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 89:422–429
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wolcott, R.D., Lopez-Leban, F., Kiran, M.D., Balaban, N. (2011). Wound Healing by an Anti-Staphylococcal Biofilm Approach. In: Flemming, HC., Wingender, J., Szewzyk, U. (eds) Biofilm Highlights. Springer Series on Biofilms, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19940-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-19940-0_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19939-4
Online ISBN: 978-3-642-19940-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)